MK-5720

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-5720, covering 2025-03-04 to 2025-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001) [Phase 1]